X

Trial Profile

A Phase 2a Randomized, Double-Blind, Placebo Controlled, Parallel Group, Safety and Efficacy Study of Oleoyl-Estrone (MP-101) in Male Obese Adults

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 30 Jul 2007

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Oleoyl estrone (Primary)
Indications Obesity
Focus Adverse reactions
Sponsors TG Therapeutics

Most Recent Events

09 Jul 2007 Status changed from in progress to completed.
09 Jul 2007 Results of Manhattan Pharmaceuticals' two Phase IIa obesity trials showed no statistically significant placebo adjusted weight loss for any of the treatment arms evaluated. The company will discontinue its obesity programs based on these results.
10 May 2007 Status changed from recruiting to in progress.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com